【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000925421-21-000109 Size: 5 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000925421-21-000107 Size: 5 KB 网页链接
$Neuronetics(STIM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-21-010320 Act: 34 Size: 15 MB 网页链接
$Neuronetics(STIM)$ 8-K Current report, item 7.01 Accession Number: 0001564590-21-010038 Act: 34 Size: 166 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-21-010040 Act: 34 Size: 899 KB 网页链接
$Neuronetics(STIM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-21-001147 Act: 34 Size: 103 KB 网页链接
$Neuronetics(STIM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001777141-21-000002 Act: 34 Size: 78 KB 网页链接
$Neuronetics(STIM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193805-21-000207 Act: 34 Size: 112 KB 网页链接
$Neuronetics(STIM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-21-001220 Act: 34 Size: 57 KB 网页链接
$Neuronetics(STIM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-21-039678 Act: 34 Size: 79 KB 网页链接